Iron Chelation with Oral Deferiprone in Patients with Thalassemia
Iron Chelation with Oral Deferiprone in Patients with Thalassemia
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
To the Editor:
Olivieri et al. (Aug. 13 issue)
1
retrospectively evaluated liver-biopsy specimens from patients with thalassemia who were treated with deferiprone and concluded that progression of fibrosis in 5 of 14 patients was due to the drug. The authors minimized the potential role of known factors that could, on their own, explain th...
Alternative Titles
Full title
Iron Chelation with Oral Deferiprone in Patients with Thalassemia
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_70078790
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70078790
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJM199812033392313
